written by reader Scheduled for June 23 rd the CD19 Vaccine for cancer.

By backoffice, June 15, 2017

A small company located in Texas will release it’s findings and results
from 110 clinical trials on a treatment centered on a patients immune
system where the T cell will recognize and phagotize the cancer cell.
The release of their findings should lead to licensing fees that should
cause the price of the stock to explode.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

190 Comments
Inline Feedbacks
View all comments
judith617
judith617
June 28, 2017 1:47 pm

This is just now:
BLCM Bellicum Pharmaceuticals Inc $0.20 (1.52%) $20.00 $49.05 (3.82%)

MBRX Moleculin Biotech Inc $0.98 (49.49%) $98.00 $100.05 (51.06%)

So far is good!

Add a Topic
4668
👍 1
Alex
Member
Alex
June 28, 2017 4:22 pm
Reply to  judith617

Hello Judith, iebought blcm and mbrx, what do you mean ?

judith617
judith617
June 29, 2017 12:07 pm
Reply to  Alex

Hi! Today unfortunately the BLCM last the earlier gain, the MBRX _2.74%. But this 2 stocks long term holding I think.

Alan
Guest
Alan
June 28, 2017 6:40 pm

It’s amazing how there haven’t been any updates from these people trying to sell their expensive memberships about where they think the stock was going to go to and no response on the 1000% the stock was supposed to go to after the so called announcement from Bellicum after the trials.

Add a Topic
5971
Add a Topic
5971
judith617
judith617
June 29, 2017 12:11 pm
Reply to  Alan

Hi! I just cancelled one of their so called membership for $2497,- !!! Yes they are very quiet! But we have here couple of very smart people, luckily they inform us with there blogs, just need to keep up reading.

RITA K
Guest
RITA K
June 29, 2017 12:09 pm

Any updates on BLCM stock, now that the 23rd. is past?

Add a Topic
5971
Richard
Guest
Richard
June 29, 2017 12:38 pm

Its strange and interesting since June 20 – BLCM traded at $12.65 and now its at $11.98, while Moleculin Biotech traded at $1.01 to $2.99 respectively – 200% increase!! I agree .. BLCM maybe a long hold, but got to be watched closely because its a small company.

ronaroosky
Guest
June 29, 2017 4:30 pm

BLCM bounced around a bit today and looks like they closed at $12.03, off about 10% since I bought it. Looks like it’s going to be a long ride. I hope they strike gold soon!

Add a Topic
210
Anthony Lasorsa
Guest
Anthony Lasorsa
June 30, 2017 4:28 pm

People bought into that a while back. And then they use you to buy into cap off their profits and then they sell the stock and you’re left with nothing.

Add a Topic
5971
Tom
Guest
Tom
July 2, 2017 7:08 am

I think this is BS. Why announce the. Results in Spain? If the results are so great why did it not make the news?

Steve
Member
Steve
July 3, 2017 12:39 am

A look at a 6 month chart for BCLM shows an intermediate term peak about March 21 at $15.50. It has been in a downtrend for the 6 months. This is demonstrated by the stock trend and the On Balance Volume indicator. In other words, while the stock has been aggressively promoted to the public, it appears that insiders have been distributing the stock to the new buyers (errrr, suckers). Last close was at $11.68. You can cast a chart at Stockcharts.com.

Add a Topic
5971
Add a Topic
5971
Add a Topic
5971
Steve
Member
Steve
July 3, 2017 3:56 pm
Reply to  Steve

A further chart look-back shows the highest high for the year made November 14, 2016 at $23.11. Downhill from there. Today’s last price at $11.70.

Steve
Member
Steve
July 3, 2017 12:14 pm

See the following article at Yahoo.com Finance:

Here’s Why Bellicum Pharmaceuticals Fell as Much as 13.8% Today

Add a Topic
4668
stevex
Member
stevex
July 6, 2017 11:47 am